Rossella Masciangelo

No ORCID on file · 2 papers in corpus

observational 2026

Clinical use of recombinant human luteinizing hormone beyond hypogonadotropic hypogonadism: a multicenter descriptive analysis from five Italian fertility centers

Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-026-01551-y

BACKGROUND: Recombinant human luteinizing hormone (rLH) was originally introduced to supplement recombinant human follicle-stimulating hormone (rFSH) for controlled ovarian stimulation (COS) in patients with hypogonadotropic hypogonadism. P…

lab-animal 2018

Safety of ovarian tissue transplantation in patients with borderline ovarian tumors

Human Reproduction ·doi:10.1093/humrep/dex352

STUDY QUESTION: Is transplantation of cryopreserved ovarian tissue from patients with borderline ovarian tumors (BOTs) a safe procedure? SUMMARY ANSWER: BOT cells were found in frozen-thawed and xenografted ovarian tissue in 1 of 11 BOT pa…